Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 16794489)

Published in J Hypertens on July 01, 2006

Authors

Jiankang Liu1, Alexandre A da Silva, Lakshmi S Tallam, John E Hall

Author Affiliations

1: Department of Physiology and Biophysics, and Center of Excellence in Cardiovascular Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA.

Articles citing this

The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep (2009) 1.29

Articles by these authors

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (2004) 11.95

Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation (2005) 8.11

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14

The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89

Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) (2005) 2.86

Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension (2004) 2.83

How to review a paper. Adv Physiol Educ (2003) 2.67

Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem (2010) 2.53

Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension (2008) 1.98

Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Arterioscler Thromb Vasc Biol (2005) 1.82

Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension (2006) 1.80

Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (2005) 1.72

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension (2003) 1.71

Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol (2004) 1.68

Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension (2002) 1.63

Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circ Res (2013) 1.42

Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension (2002) 1.40

Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension (2004) 1.39

Pathophysiology and treatment of obesity hypertension. Curr Pharm Des (2004) 1.37

Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension (2011) 1.30

Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension (2004) 1.29

The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep (2009) 1.29

Racial and ethnic differences in blood pressure: biology and sociology. Circulation (2006) 1.27

Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep (2003) 1.21

Hypertension: physiology and pathophysiology. Compr Physiol (2012) 1.18

Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Physiol Regul Integr Comp Physiol (2006) 1.18

Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens (2003) 1.18

Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension (2003) 1.14

Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.13

Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes (2005) 1.13

A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes (2009) 1.10

Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol (2011) 1.06

Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther (2009) 1.06

Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. Am J Physiol Heart Circ Physiol (2008) 1.04

Reduction in the incidence of alveolar osteitis in patients treated with the SaliCept patch, containing Acemannan hydrogel. J Oral Maxillofac Surg (2002) 1.04

Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation? Hypertension (2005) 1.00

Hemivertebra excision in children via simultaneous anterior and posterior exposures. J Pediatr Orthop (2004) 0.98

Cervical kyphosis associated with anteroposterior dissociation and quadriparesis in Larsen's syndrome. J Pediatr Orthop (2005) 0.98

Operative treatment of scoliosis in patients with a Fontan circulation. Spine (Phila Pa 1976) (2006) 0.97

Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. Am J Physiol Regul Integr Comp Physiol (2013) 0.97

Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. Am J Physiol Regul Integr Comp Physiol (2013) 0.96

Obesity, physical inactivity, and risk for cardiovascular disease. Am J Med Sci (2002) 0.95

Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors. Hypertension (2012) 0.95

Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol (2011) 0.94

Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats. Peptides (2013) 0.94

Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arterioscler Thromb Vasc Biol (2005) 0.94

The safety and efficacy of spinal instrumentation in children with congenital spine deformities. Spine (Phila Pa 1976) (2004) 0.93

Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.93

Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. J Hypertens (2010) 0.91

Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension (2013) 0.91

Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease. Am J Physiol Renal Physiol (2011) 0.90

Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life (2013) 0.90

Role of leptin and central nervous system melanocortins in obesity hypertension. Curr Opin Nephrol Hypertens (2013) 0.90

Cardiovascular, renal, and metabolic responses to chronic central administration of agouti-related peptide. Hypertension (2004) 0.89

Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population. Nephrol Dial Transplant (2004) 0.88

Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation. Hypertension (2011) 0.87

Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight. Pflugers Arch (2012) 0.86

The promise of translational physiology. Am J Physiol Heart Circ Physiol (2002) 0.86

Increased expression of vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats. Microcirculation (2004) 0.85

The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda) (2014) 0.85

Perinatal salt restriction: a new pathway to programming insulin resistance and dyslipidemia in adult wistar rats. Pediatr Res (2004) 0.84

Chronic effects of centrally administered adiponectin on appetite, metabolism and blood pressure regulation in normotensive and hypertensive rats. Peptides (2012) 0.84

Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs. Physiol Genomics (2004) 0.83

Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension (2004) 0.83

Chronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet. J Hypertens (2011) 0.82

Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertens Res (2013) 0.82

Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity. Am J Physiol Regul Integr Comp Physiol (2012) 0.81

Direct recording of renal sympathetic nerve activity in unrestrained, conscious mice. Hypertension (2012) 0.80

Chronic cardiovascular and renal actions of leptin during hyperinsulinemia. Am J Physiol Regul Integr Comp Physiol (2003) 0.79

The national high blood pressure education program: thirty years and counting. Hypertension (2002) 0.79

The promise of translational physiology. J Neurophysiol (2003) 0.78

World Hypertension Day 2007. Hypertension (2007) 0.78

The pioneering use of systems analysis to study cardiac output regulation. Am J Physiol Regul Integr Comp Physiol (2004) 0.78

Hypertension: pathways to success. Hypertension (2008) 0.78

Maternal high-sodium intake alters the responsiveness of the renin-angiotensin system in adult offspring. Life Sci (2012) 0.76

Spinal arthrodesis for scoliosis in Down syndrome. J Pediatr Orthop (2003) 0.76